Skip to the page content
Your donations
Passes our checks

Urological Research Network Foundation

EIN 86-3560723 · Hialeah, FL

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong90 out of 100GovernanceWeak34 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE UROLOGICAL NETWORK FOUNDATION IS A SCIENTIFIC ORGANIZATION THAT AIMS TO SUPPORT PATIENT'S AWARENESS, EDUCATION THROUGH INDEPENDENT SUPPORT OUTCOMES-BASED RESEARCH IN THE PUBLIC INTEREST EVALUATING BOTH MEDICATIONS AND MEDICAL DEVICES USED FOR UROLOGICAL CONDITIONS. SINCE 40% OF UROLOGICAL CONDITIONS ARE ASSOCIATED WITH A CANCER DIAGNOSIS, WE AIM TO SUPPORT RESEARCH, TRAINING AND EDUCATIONAL PROGRAMS THAT IMPROVE THE PREVENTION, DETECTION, AND TARGETED TREATMENT OF GENITOURINARY MALIGNANCIES AND/OR PROGRAMS THAT SEEK TO CURE IT FOR GOOD.

Income
$361,284
Spending
$323,907
Spent on programs
100%
Reserves
23.4 months of spending
Largest source of income
donations and private grants, 62%
Employees
0

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 90 out of 100. Higher than 64% of charities in its peer group (medical research, $250k to $1m).

  • Reserves

    35 of 35

    Spendable reserves would cover 23.4 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 10% of income.

  • Income trend

    5 of 15

    Income fell 17% on the year before.

  • Spending floor

    15 of 15

    100% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Weak: 34 out of 100. Higher than 7% of charities in its peer group (medical research, $250k to $1m).

  • Independent board

    5 of 25

    0 of 4 voting board members are independent.

  • Conflict of interest policy

    0 of 15

    Reports no written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Independent check of accounts

    12 of 15

    Its accounts were reviewed or compiled by an independent accountant, but not audited.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $200,344 spent. TO ACHIEVE THESE GOALS, THE FOUNDATION WORKS TO SUPPORT PATIENTS AWARENESS EDUCATION THROUGH INDEPENDENT SUPPORT, AND RESEARCH MEDICATIONS AND MEDICAL DEVICES USED FOR UROLOGICA CONDITIONS.
  2. $89,563 spent. THE CLINICAL RESEARCH IN MRI FUSION THERAPIES FOR PROSTATE CANCER PROGRAM IS A MULTIDISCIPLINARY INITIATIVE FOCUSED ON ADVANCING MINIMALLY INVASIVE, IMAGE-GUIDED TREATMENTS FOR LOCALIZED PROSTATE CANCER. THIS RESEARCH LINE INTEGRATES STATE-OF-THE-ART MRI FUSION TECHNOLOGY TO ENHANCE PRECISION IN DIAGNOSIS, ABLATION, AND FOLLOW-UP, SEEKING TO IMPROVE ONCOLOGICAL OUTCOMES WHILE MINIMIZING SIDE EFFECTS AND PRESERVING PATIENTS' QUALITY OF LIFE.
  3. $34,000 spent. THE FOUNDATION SUPPORTED AND COLLABORATED IN CLINICAL RESEARCH ACTIVITIES AIMED AT ADVANCING INNOVATIVE TREATMENTS FOR PROSTATE CANCER. DURING THE REPORTING PERIOD, THE FOUNDATION CONTRIBUTED TO THE STUDY ENTITLED "NATURAL HISTORY OF PATIENTS UNDERGOING TRANSPERINEAL FUSION BIOPSIES TO TRANSPERINEAL FUSION CRYOABLATION: 5-YEAR OUTCOMES," WHICH WAS SUBSEQUENTLY PUBLISHED IN A PEER-REVIEWED MEDICAL JOURNAL. THE STUDY EVALUATED LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH TRANSPERINEAL FUSION-GUIDED BIOPSY AND CRYOABLATION PROCEDURES, CONTRIBUTING VALUABLE SCIENTIFIC DATA TO IMPROVE PATIENT CARE, TREATMENT EFFECTIVENESS, AND EVIDENCE-BASED MEDICAL PRACTICES.SI LA FUNDACIN APORT FINANCIAMIENTO, DATOS, RECLUTAMIENTO DE PACIENTES O APOYO LOGSTICO, SE PUEDE ADAPTAR LA REDACCIN PARA REFLEJAR ESPECFICAMENTE ESE ROL. POR EJEMPLO:THE FOUNDATION PROVIDED SUPPORT FOR RESEARCH, DATA COLLECTION, AND CLINICAL COLLABORATION RELATED TO THE PUBLISHED STUDY ENTITLED "NATURAL HISTORY OF PATIENTS UNDERGOING TRANSPERINEAL FUSION BIOPSIES TO TRANSPERINEAL FUSION CRYOABLATION: 5-YEAR OUTCOMES," CONTRIBUTING TO THE ADVANCEMENT OF MEDICAL KNOWLEDGE AND IMPROVED TREATMENT OPTIONS FOR PATIENTS WITH PROSTATE CANCER. THE FOUNDATION SUPPORTED AND COLLABORATED IN CLINICAL RESEARCH ACTIVITIES AIMED AT ADVANCING INNOVATIVE TREATMENTS FOR PROSTATE CANCER. DURING THE REPORTING PERIOD, THE FOUNDATION CONTRIBUTED TO THE STUDY ENTITLED "NATURAL HISTORY OF PATIENTS UNDERGOING TRANSPERINEAL FUSION BIOPSIES TO TRANSPERINEAL FUSION CRYOABLATION: 5-YEAR OUTCOMES," WHICH WAS SUBSEQUENTLY PUBLISHED IN A PEER-REVIEWED MEDICAL JOURNAL. THE STUDY EVALUATED LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH TRANSPERINEAL FUSION-GUIDED BIOPSY AND CRYOABLATION PROCEDURES, CONTRIBUTING VALUABLE SCIENTIFIC DATA TO IMPROVE PATIENT CARE, TREATMENT EFFECTIVENESS, AND EVIDENCE-BASED MEDICAL PRACTICES.SI LA FUNDACIN APORT FINANCIAMIENTO, DATOS, RECLUTAMIENTO DE PACIENTES O APOYO LOGSTICO, SE PUEDE ADAPTAR LA REDACCIN PARA REFLEJAR ESPECFICAMENTE ESE ROL. POR EJEMPLO:THE FOUNDATION PROVIDED SUPPORT FOR RESEARCH, DATA COLLECTION, AND CLINICAL COLLABORATION RELATED TO THE PUBLISHED STUDY ENTITLED "NATURAL HISTORY OF PATIENTS UNDERGOING TRANSPERINEAL FUSION BIOPSIES TO TRANSPERINEAL FUSION CRYOABLATION: 5-YEAR OUTCOMES," CONTRIBUTING TO THE ADVANCEMENT OF MEDICAL KNOWLEDGE AND IMPROVED TREATMENT OPTIONS FOR PATIENTS WITH PROSTATE CANCER.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 2021.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.